BioHistory Moment: Food Additives Amendments passed
On September 6, 1958, The Food Additives Amendments were passed, requiring that food
additives, including preservatives, emulsifiers, and other functional additives,
be subject to premarket testing.
Today, the FDA must review the safety of food and color additives before manufacturers
and distributors can market them. To initiate this review, the FDA requires sponsors
to submit a petition or notification that includes test data demonstrating the
safety of the intended use of the substance.
 More...
Learn about Seattle's Life Science Incubator Facility
Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with
modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical
space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington,
the Fred Hutchinson Cancer Research Center, and more.
Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Georgia, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
- Allergan resolves investigation of past sales and marketing practices related to BOTOX(R) Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
Allergan, Inc. September 01, 2010
- Merck and Cardiome annoumnce BRINAVESS for infusion approved in the European Union Merck and Cardiome Pharma Corp. announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation.
Merck & Co., Inc. September 01, 2010
- BARDA funds development of new way to treat illness from acute radiation The HHS Biomedical Advanced Research and Development Authority awarded a $153 million contract to Cellerant Therapeutics of San Carlos, Calif., to continue developing a new way to treat an illness caused by exposure to high levels of ionizing radiation which can damage the body’s cells.
U.S. Health & Human Services September 01, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Georgia's BioHistory
Why is there a life science industry in Georgia? Is the industry
growing? What do other states have?
Through Georgia BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Georgia.
More...
BioEvolution Posters
More...
September: Ovarian Cancer Awareness Month
In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths.
An estimated one woman in 58 will develop ovarian cancer during her lifetime. The
American Cancer Society estimates that in 2008, there will be 21,650 new cases of
ovarian cancer and 15,520 women will die from ovarian cancer.
The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and
increasing education about ovarian cancer. Established in 1995, the organization is
committed to improving the survival rate and quality of life for women with this cancer.
More...
BioFact
(1933) - Fewer than 1% of all the agricultural land in the Corn Belt has hybrid corn growing on it; by 1943, however, hybrids will cover more than 78% of the same land.
It's a Small World
|
| |
cholera_sm.jpg
| |
Science Quote
"Science is the knowledge of consequences, and dependence of one fact upon another."
| - |
Thomas Hobbes, English philosopher, author
|
|
(1588-1679)
|
|
